Advertisement

Abstract

The elucidation of the human genome sequence has made it possible to identify genetic alterations in cancers in unprecedented detail. To begin a systematic analysis of such alterations, we determined the sequence of well-annotated human protein-coding genes in two common tumor types. Analysis of 13,023 genes in 11 breast and 11 colorectal cancers revealed that individual tumors accumulate an average of ∼90 mutant genes but that only a subset of these contribute to the neoplastic process. Using stringent criteria to delineate this subset, we identified 189 genes (average of 11 per tumor) that were mutated at significant frequency. The vast majority of these genes were not known to be genetically altered in tumors and are predicted to affect a wide range of cellular functions, including transcription, adhesion, and invasion. These data define the genetic landscape of two human cancer types, provide new targets for diagnostic and therapeutic intervention, and open fertile avenues for basic research in tumor biology.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (1133427_som_tables.zip)
File (sjoblom.som.revision.1.pdf)
File (sjoblom.som.revision.1.table_s5.pdf)
File (sjoblom.som.revision.1.table_s6.pdf)

References and Notes

1
B. Vogelstein, K. W. Kinzler, Nat. Med.10, 789 (2004).
2
P. A. Futreal et al., Nat. Rev. Cancer4, 177 (2004).
3
A. Bardelli, V. E. Velculescu, Curr. Opin. Genet. Dev.15, 5 (2005).
4
B. Vogelstein, K. W. Kinzler, The Genetic Basis of Human Cancer (McGraw-Hill, Toronto, 2002).
5
D. M. Parkin, F. Bray, J. Ferlay, P. Pisani, CA Cancer J. Clin.55, 74 (2005).
6
CCDS Database (www.ncbi.nlm.nih.gov/CCDS).
7
See supporting material on Science Online.
8
B. Ewing, P. Green, Genome Res.8, 186 (1998).
9
C. Lengauer, K. W. Kinzler, B. Vogelstein, Nature396, 643 (1998).
10
L. A. Loeb, Cancer Res.61, 3230 (2001).
11
C. Greenman, R. Wooster, P. A. Futreal, M. R. Stratton, D. F. Easton, Genetics173, 2187 (2006).
12
S. E. Kern, J. M. Winter, Cancer Biol. Ther.5, 349 (2006).
13
T. L. Wang et al., Proc. Natl. Acad. Sci. U.S.A.99, 3076 (2002).
14
D. Shenet al., in preparation.
15
P. Stephens et al., Nat. Genet.37, 590 (2005).
16
H. Strohmaier et al., Nature413, 316 (2001).
17
A. Bardelli et al., Science300, 949 (2003).
18
Z. Wang et al., Cancer Res.64, 2998 (2004).
19
G. J. Riggins et al., Nat. Genet.13, 347 (1996).
20
K. Eppert et al., Cell86, 543 (1996).
21
J.-L. Ku et al., Cancer Lett. (2006).
22
A. Duval et al., Cancer Res.59, 4213 (1999).
23
S. Markowitz et al., Science268, 1336 (1995).
24
C. A. Landis et al., Nature340, 692 (1989).
25
B. Padmanabhan et al., Mol. Cell21, 689 (2006).
26
O. Bluteau et al., Nat. Genet.32, 312 (2002).
27
K. Salassidis et al., Cancer Res.60, 2786 (2000).
28
Y. Arai et al., Blood89, 3936 (1997).
29
K. W. Kinzler et al., Science236, 70 (1987).
30
H. Varmus, Science312, 1162 (2006).
31
X. X. Tang, G. M. Brodeur, B. G. Campling, N. Ikegaki, Clin. Cancer Res.5, 455 (1999).
32
M. Ruault, M. E. Brun, M. Ventura, G. Roizes, A. De Sario, Gene284, 73 (2002).
33
M. Tanaka et al., Cancer Res.55, 3228 (1995).
34
A. Sasaki, Y. Masuda, Y. Ohta, K. Ikeda, K. Watanabe, J. Biol. Chem.276, 17871 (2001).
35
M. Sato et al., Genes Chromosomes Cancer44, 405 (2005).
36
Y. Onishi, K. Tsukada, J. Yokota, A. Raz, Clin. Exp. Metastasis20, 51 (2003).
37
M. Hollstein, D. Sidransky, B. Vogelstein, C. C. Harris, Science253, 49 (1991).
38
J. L. Bos et al., Nature327, 293 (1987).
39
R. Brent, Cell100, 169 (2000).
40
T. Ideker et al., Science292, 929 (2001).
41
S. L. Ooi et al., Trends Genet.22, 56 (2006).
42
T. Soussi, G. Lozano, Biochem. Biophys. Res. Commun.331, 834 (2005).
43
M. Olivier, S. P. Hussain, C. Caron de Fromentel, P. Hainaut, C. C. Harris, IARC Sci. Publ. 157, 247 (2004).
44
J. F. Costello et al., Nat. Genet.24, 132 (2000).
45
A. H. Owens, D. S. Coffey, S. B. Baylin, Eds., Tumor Cell Heterogeneity (Academic Press, New York, 1982), pp. 441–460.
46
K. D. Pruitt, T. Tatusova, D. R. Maglott, Nucleic Acids Res.33, D501 (2005).
48
Y. H. Rogers, J. C. Venter, Nature437, 326 (2005).
49
We thank J. Lutterbaugh, E. Lawrence, and L. Beard for assistance with cell culture and DNA preparation; E. Suh, D. Smith, K. Makowski, and the Agencourt sequencing team for assistance with automated sequencing; S. Kern for helpful comments on the manuscript; and R. J. Vogelstein and J. T. Vogelstein for assistance with statistical analyses. Supported by the Virginia and D. K. Ludwig Fund for Cancer Research; NIH grants CA 121113, CA 43460, CA 57345, CA 62924, GM 07309, RR 017698, P30-CA43703, and CA109274; NCI Division of Cancer Prevention contract HHSN261200433002C; Department of Defense grant DAMD17-03-1-0241; and the Pew Charitable Trusts, the Palmetto Health Foundation, the Maryland Cigarette Restitution Fund, the State of Ohio Biomedical Research and Technology Transfer Commission, the Clayton Fund, the Blaustein Foundation, the National Colorectal Cancer Research Alliance, the Avon Foundation, the Flight Attendant Medical Research Institute, and the V Foundation for Cancer Research.

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 314 | Issue 5797
13 October 2006

Article versions

You are viewing the most recent version of this article.

Submission history

Received: 3 August 2006
Accepted: 30 August 2006
Published in print: 13 October 2006

Permissions

Request permissions for this article.

Notes

Supporting Online Material
www.sciencemag.org/cgi/content/full/1133427/DC1
Materials and Methods
Figs. S1 and S2
Tables S1 to S5
References

Authors

Affiliations

Tobias Sjöblom*
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Siân Jones*
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Laura D. Wood*
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
D. Williams Parsons*
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Jimmy Lin
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Thomas D. Barber
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Diana Mandelker
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Rebecca J. Leary
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Janine Ptak
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Natalie Silliman
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Steve Szabo
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Phillip Buckhaults
Department of Pathology and Microbiology, Center for Colon Cancer Research, and South Carolina Cancer Center, Division of Basic Research, University of South Carolina School of Medicine, Columbia, SC 29229, USA.
Christopher Farrell
Department of Pathology and Microbiology, Center for Colon Cancer Research, and South Carolina Cancer Center, Division of Basic Research, University of South Carolina School of Medicine, Columbia, SC 29229, USA.
Paul Meeh
Department of Pathology and Microbiology, Center for Colon Cancer Research, and South Carolina Cancer Center, Division of Basic Research, University of South Carolina School of Medicine, Columbia, SC 29229, USA.
Sanford D. Markowitz
Department of Medicine, Ireland Cancer Center, and Howard Hughes Medical Institute, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH 44106, USA.
Joseph Willis
Department of Pathology and Ireland Cancer Center, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH 44106, USA.
Dawn Dawson
Department of Pathology and Ireland Cancer Center, Case Western Reserve University and University Hospitals of Cleveland, Cleveland, OH 44106, USA.
James K. V. Willson
Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Adi F. Gazdar
Hamon Center for Therapeutic Oncology Research and Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
James Hartigan
Agencourt Bioscience Corporation, Beverly, MA 01915, USA.
Leo Wu
Soft Genetics LLC, State College, PA 16803, USA.
Changsheng Liu
Soft Genetics LLC, State College, PA 16803, USA.
Giovanni Parmigiani
Departments of Oncology, Biostatistics, and Pathology, Johns Hopkins Medical Institutions, Baltimore, MD 21205, USA.
Ben Ho Park
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Kurtis E. Bachman
Department of Radiation Oncology and Department of Biochemistry and Molecular Biology, Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Nickolas Papadopoulos
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Bert Vogelstein [email protected]
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Kenneth W. Kinzler [email protected]
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Victor E. Velculescu [email protected]
Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.

Notes

To whom correspondence should be addressed. E-mail: [email protected] (B.V.); [email protected] (K.W.K.); [email protected] (V.E.V.)

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Genome-wide repeat landscapes in cancer and cell-free DNA, Science Translational Medicine, 16, 738, (2024)./doi/10.1126/scitranslmed.adj9283
    Abstract
  2. Targeting the Hedgehog Pathway in Rhabdomyosarcoma, Cancers, 15, 3, (727), (2023).https://doi.org/10.3390/cancers15030727
    Crossref
  3. Single-Cell Analysis of Circulating Tumor Cells from Patients with Colorectal Cancer Captured with a Dielectrophoresis-Based Micropore System, Biomedicines, 11, 1, (203), (2023).https://doi.org/10.3390/biomedicines11010203
    Crossref
  4. Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors, Frontiers in Immunology, 14, (2023).https://doi.org/10.3389/fimmu.2023.1119498
    Crossref
  5. The complex nature of heterogeneity and its roles in breast cancer biology and therapeutic responsiveness, Frontiers in Endocrinology, 14, (2023).https://doi.org/10.3389/fendo.2023.1083048
    Crossref
  6. Methylation of the tumor associated genes in head and neck squamous cell carcinoma, Head and Neck Tumors (HNT), 12, 4, (61-70), (2023).https://doi.org/10.17650/2222-1468-2022-12-4-61-70
    Crossref
  7. Clinical Progress of TTN and OBSCN Axes in Liver Metastasis of Colorectal Cancer, Advances in Clinical Medicine, 13, 03, (3510-3514), (2023).https://doi.org/10.12677/ACM.2023.133502
    Crossref
  8. Metabolic reprogramming in colorectal cancer: regulatory networks and therapy, Cell & Bioscience, 13, 1, (2023).https://doi.org/10.1186/s13578-023-00977-w
    Crossref
  9. A Switch of G Protein-Coupled Receptor Binding Preference from Phosphoinositide 3-Kinase (PI3K)–p85 to Filamin A Negatively Controls the PI3K Pathway, Molecular and Cellular Biology, 32, 5, (1004-1016), (2023).https://doi.org/10.1128/MCB.06252-11
    Crossref
  10. A Weak C′ Box Renders U3 snoRNA Levels Dependent on hU3-55K Binding, Molecular and Cellular Biology, 31, 12, (2404-2412), (2023).https://doi.org/10.1128/MCB.05067-11
    Crossref
  11. See more
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Purchase digital access to this article

Download and print this article for your personal scholarly, research, and educational use.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media